Fresenius Medical Care AG's total inventories for the quarter that ended in Mar. 2026 was €2,303 Mil. Fresenius Medical Care AG's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was €2,222 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Fresenius Medical Care AG's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was €-47.26.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Fresenius Medical Care AG's Days Inventory for the
three
months ended in Mar. 2026 was 59.06.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Fresenius Medical Care AG's Inventory Turnover for the quarter that ended in Mar. 2026 was 1.54.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Fresenius Medical Care AG's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.48.
Fresenius Medical Care AG (XTER:FME) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Fresenius Medical Care AG's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Fresenius Medical Care AG's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Fresenius Medical Care AG Total Inventories Related Terms
Fresenius Medical Care AG Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Fresenius Medical Care AG (XTER:FME) has a Total Inventories of €2,303 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Fresenius Medical Care AG and its competitors.
Is Fresenius Medical Care AG's Total Inventories too high?
Fresenius Medical Care AG's current Total Inventories is €2,303 Mil. Overall, Fresenius Medical Care AG has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Total Inventories compare to HCA and THC?
Fresenius Medical Care AG's Total Inventories of €2,303 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Healthcare Providers & Services company?
A good Total Inventories depends on the Healthcare Providers & Services industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current Total Inventories is €2,303 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (XTER:FME) is currently considered Fairly Valued. The stock's GF Value™ is €41.29, compared to a current price of €41.55 — trading 0.6% above its estimated fair value. The current Total Inventories is €2,303 Mil. Fresenius Medical Care AG's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Fresenius Medical Care AG (XTER:FME), the current Total Inventories is €2,303 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (XTER:FME) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be overvalued.
The current stock price of €41.55 is trading 0.6% above its estimated GF Value™ of €41.29.
GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.
Key valuation signals for XTER:FME:
Total Inventories: €2,303 Mil
GF Value™: €41.29 vs. price of €41.55 (0.6% above fair value)
No single metric tells the full story. See the XTER:FME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
70GF Score
Get the complete analysis for XTER:FME
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:FME has been successfully added to your 
